Sign in
Groups
Researchers
Results
Funding
Convener
:
CYTOGNOS, S.L.
Scope
National (2)
Regime
Direct grant (2)
2 funding
- 61,351€
data available since 1999
2000
POTENCIAL DIAGNOSTICO, PRONOSTICO Y TERAPEUTICO DE VpreB, INMUNOCLON B-MAD 688, EN LEUCEMIA LINFATICA AGUDA B
euro
30,675.66
1999
POTENCIAL DIAGNOSTICO, PRONOSTICO Y TERAPEUTICO DE VpreB, INMUNOCLON B-MAD 688, EN LEUCEMIA LINFATICA AGUDA B
euro
30,675.66
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de